Raymond James Financial’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Raymond James Financial's CANC Position: Q3 2026 in Review
Raymond James Financial opened a new position in Tema Oncology ETF (CANC) in Q3 2026: 24,513 shares worth $1.03M. The stake represents ﹤0.01% of the portfolio and ranks #4021 among its holdings. This is a return to the name: Raymond James Financial previously reported a position in CANC as recently as Q2 2025.
Raymond James Financial first reported a position in CANC in Q2 2025 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Raymond James Financial held 24,513 shares of Tema Oncology ETF worth $1.03M as of Q3 2026.
- Tema Oncology ETF was a new Raymond James Financial position in Q3 2026.
- Tema Oncology ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q3 2026, its #4021 holding.
- Raymond James Financial first reported a position in Tema Oncology ETF in Q2 2025 and has held it in 2 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.